Lymphedema News and Research

RSS
Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for draining excess fluid from the body and is a key component of the immune system, is damaged or altered. In breast cancer patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that six percent to 40 percent of patients with breast cancer develop lymphedema, and that it often occurs within the first two years after surgery. For some cancer survivors and others at risk, a low level lymphedema can occur 10 years to 15 years following the initial primary treatment and develop into a condition that has a serious impact on overall health and quality of life.
New imaging probes can non-invasively detect breast cancer lymph node metastasis

New imaging probes can non-invasively detect breast cancer lymph node metastasis

Prospective surveillance model can reduce treatment costs for breast cancer-related lymphedema

Prospective surveillance model can reduce treatment costs for breast cancer-related lymphedema

Benefits of exercise for breast cancer patients with lymphedema

Benefits of exercise for breast cancer patients with lymphedema

Prox1 gene plays a critical role in formation and maintenance of lymphatic system

Prox1 gene plays a critical role in formation and maintenance of lymphatic system

Conference highlights advances in evidence-based integrative therapies for cancer

Conference highlights advances in evidence-based integrative therapies for cancer

NIH awards $452,218 for research on proinflammatory biomarkers and post-breast cancer lymphedema

NIH awards $452,218 for research on proinflammatory biomarkers and post-breast cancer lymphedema

New sleepwear now available for post-surgery breast cancer patients

New sleepwear now available for post-surgery breast cancer patients

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

New studies on breast cancer screening, treatment and survival

New studies on breast cancer screening, treatment and survival

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Cancer Information Service celebrates helping one million Canadians

Cancer Information Service celebrates helping one million Canadians

Breast cancer survival and lymph nodes

Breast cancer survival and lymph nodes

Women with early-stage breast cancer do not benefit from lymph node removal

Women with early-stage breast cancer do not benefit from lymph node removal

Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 study

Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 study

Additional radiation treatment shows promise for breast cancer surgery patients

Additional radiation treatment shows promise for breast cancer surgery patients

Lx Therapies, BioCis partner to form Laurantis Pharma

Lx Therapies, BioCis partner to form Laurantis Pharma

Breast cancer specialists offer new technology for patients to detect early-stage lymphedema

Breast cancer specialists offer new technology for patients to detect early-stage lymphedema

Nonsurgical methods to identify critical lymph nodes in patients with breast cancer

Nonsurgical methods to identify critical lymph nodes in patients with breast cancer

Study finds breast cancer patients do not benefit from axillary lymph node dissection

Study finds breast cancer patients do not benefit from axillary lymph node dissection

Accelerated completes acquisition of SPTRS, Burkam

Accelerated completes acquisition of SPTRS, Burkam